Skip to main content
Log in

Update in Pulmonary Carcinoid Tumors: A Review Article

  • Original Articles
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Pulmonary carcinoid tumors are neuroendocrine malignant tumors that make up 1% to 2% of all lung tumors. According to histopathologic criteria, carcinoids can be divided into typical (TC) and atypical (AC) carcinoids. Carcinoids can be placed in a spectrum of neuroendocrine tumors, ranging from low-grade malignant TC to intermediate AC to high-grade large-cell neuroendocrine carcinoma and small-cell lung carcinoma. Familial pulmonary carcinoids are rare. The most common symptoms are hemoptysis, cough, recurrent pulmonary infection, fever, chest discomfort and chest pain, unilateral wheezing, and shortness of breath. Paraneoplastic syndromes are rare and include carcinoid syndrome, Cushing’s syndrome, and ectopic growth hormone–releasing hormone secretion. The diagnosis is usually established by flexible bronchoscopy and biopsy, although occasionally this can result in severe hemorrhage. Immunoscintigraphy by somatostatin analogs can also be useful in diagnosis. The treatment of choice is surgical resection, and prognosis is relatively good in TC, although it is worse in AC. The role of radiotherapy and chemotherapy as part of multimodality treatment or palliation is still debated.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. Lubarch O. Ueber den primären Krebs des Ileum, nebst Bemerkungen über das gleichzeitige Vorkommen von Krebs und Tuberkolose. Virchows Arch 1888; 111:280–317.

    Article  Google Scholar 

  2. Fröhlich F. Die “Helle Zelle” der Bronchialschleimhaut und ihre Beziehungen zum Problem der Chemoreceptoren. Frankfurter Z Pathol 1949; 60:517.

    Google Scholar 

  3. Travis WD, Rush W, Flieder DB, et al. Survival analysis of 200 pulmonary neuroendocrine tumors with clarification of criteria for atypical carcinoid and its separation from typical carcinoid. Am J Surg Pathol 1998; 22:934–44.

    Article  PubMed  CAS  Google Scholar 

  4. Arrigoni MG, Woolner LB, Bernatz PE. Atypical carcinoid tumors of the lung. J Thorac Cardiovasc Surg 1972; 64:413–21.

    PubMed  CAS  Google Scholar 

  5. Travis WD, Colby TV, Corrin B. Histological Typing of Lung and Pleural Tumours. 3rd ed. Berlin: Springer, 1999.

    Google Scholar 

  6. Quaedvlieg PFHJ, Visser O, Lamers CBHW, Janssen-Heijen MLG, Taal BG. Epidemiology and survival in patients with carcinoid disease in the Netherlands. An epidemiological study with 2391 patients. Ann Oncol 2001; 12:1295–300.

    Article  PubMed  CAS  Google Scholar 

  7. Skuladottir H, Hirsch FR, Hansen HH, Olsen JH. Pulmonary neuroendocrine tumors: incidence and prognosis of histological subtypes. A population-based study in Denmark. Lung Cancer 2002; 37:127–35.

    Article  PubMed  Google Scholar 

  8. Filosso PL, Rena O, Donati G, et al. Bronchial carcinoid tumors: surgical management and long-term outcome. J Thorac Cardiovasc Surg 2002; 123:303–9.

    Article  PubMed  Google Scholar 

  9. El Jamal M, Nicholson AG, Goldstraw P. The feasibility of conservative resection for carcinoid tumors: is pneumonectomy ever necessary for uncomplicated cases? Eur J Cardiothorac Surg 2000; 18:301–6.

    Article  PubMed  CAS  Google Scholar 

  10. Onuki N, Wistuba II, Travis WD, et al. Genetic changes in the spectrum of neuroendocrine lung tumors. Cancer 1999; 85:600–7.

    Article  PubMed  CAS  Google Scholar 

  11. Beasley MB, Thunnissen FBJM, Brambilla E, et al. Pulmonary atypical carcinoid: predictors of survival in 106 cases. Hum Pathol 2000; 31:1255–65.

    Article  PubMed  CAS  Google Scholar 

  12. Erasmus JJ, McAdams HP, Patz EF Jr, Coleman RE, Ahuja V, Goodman PC. Evaluation of primary pulmonary carcinoid tumors using FDG PET. AJR Am J Roentgenol 1998; 170:1369–73.

    PubMed  CAS  Google Scholar 

  13. Kayser K, Kayser C, Rahn W, Bovin NV, Gabius H-J. Carcinoid tumors of the lung: immuno- and ligandohistochemistry, analysis of integrated optical density, syntactic structure analysis, clinical data, and prognosis of patients treated surgically. J Surg Oncol 1996; 63:99–106.

    Article  PubMed  CAS  Google Scholar 

  14. Harpole DH Jr, Feldman JM, Buchanan S, Young WG, Wolfe WG. Bronchial carcinoid tumors: a retrospective analysis of 126 patients. Ann Thorac Surg 1992; 54:50–5.

    Article  PubMed  Google Scholar 

  15. Vadasz P, Palffy G, Egervary M, Schaff Z. Diagnosis and treatment of bronchial carcinoid tumors: clinical and pathological review of 120 operated patients. Eur J Cardiothorac Surg 1993; 7:8–11.

    Article  PubMed  CAS  Google Scholar 

  16. Martini N, Zaman MB, Bains MS, et al. Treatment and prognosis in bronchial carcinoid involving regional lymph nodes. J Thorac Cardiovasc Surg 1994; 107:1–7.

    PubMed  CAS  Google Scholar 

  17. Sen F, Borczuk AC. Combined carcinoid tumor of the lung: a combination of carcinoid and adenocarcinoma. Lung Cancer 1998; 2:53–8.

    Article  Google Scholar 

  18. Ullmann R, Schwendel A, Klemen H, Wolf G, Petersen I, Popper HH. Unbalanced chromosomal aberrations in neuroendocrine lung tumors as detected by comparative genomic hybridization. Hum Pathol 1998; 29:1145–9.

    Article  PubMed  CAS  Google Scholar 

  19. Przygodzki RM, Finkelstein SD, Langer JC, et al. Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors: correlation with histological subtype and clinical outcome. Am J Pathol 1996; 148:1531–41.

    PubMed  CAS  Google Scholar 

  20. Brambilla E, Negoescu A, Gazzeri S, et al. Apoptosis-related factors p53, Bcl2, and Bax in neuroendocrine lung tumors. Am J Pathol 1996; 149:1941–52.

    PubMed  CAS  Google Scholar 

  21. Gouyer V, Gazzeri S, Bolon I, Drevet C, Brambilla C, Brambilla E. Mechanism of retinoblastoma gene inactivation in the spectrum of neuroendocrine lung tumors. Am J Respir Cell Mol Biol 1998; 18:188–96.

    PubMed  CAS  Google Scholar 

  22. Gouyer V, Gazzeri S, Brambilla E, et al. Loss of heterozygosity at the RB locus correlates with loss of RB protein in primary malignant neuro-endocrine lung carcinomas. Int J Cancer 1994; 58:18–24.

    Article  Google Scholar 

  23. Gugger M, Burckhardt E, Kappeler A, Hirsiger H, Laissue JA, Mazzucchelli L. Quantitative expression of structural genomic alterations in the spectrum of neuroendocrine lung carcinomas. J Pathol 2002; 196:408–15.

    Article  PubMed  CAS  Google Scholar 

  24. Ullmann R, Petzmann S, Klemen H, Fraire AE, Hasleton P, Popper HH. The position of pulmonary carcinoids within the spectrum of neuroendocrine tumors of the lung and other tissues. Genes Chromosomes Cancer 2002; 34:78–85.

    Article  PubMed  CAS  Google Scholar 

  25. Rusch VW, Klimstra DS, Venkatraman ES. Molecular markers help characterize neuroendocrine lung tumors. Ann Thorac Surg 1996; 62:798–809.

    Article  PubMed  CAS  Google Scholar 

  26. Walch AK, Zitzelsberger HF, Aubele MM, et al. Typical and atypical carcinoid tumors of the lung are characterized by 11q deletions as detected by comparative genomic hybridization. Am J Pathol 1998; 153:1089–98.

    PubMed  CAS  Google Scholar 

  27. Debelenko LV, Brambila E, Agarwal SK, et al. Identification of MEN1 gene mutations in sporadic carcinoid tumors of the lung. Hum Mol Genet 1997; 6:2285–90.

    Article  PubMed  CAS  Google Scholar 

  28. Debelenko LV, Swalwell JI, Kelley MJ, et al. MEN1 gene mutation analysis of high-grade neuroendocrine lung carcinoma. Genes Chromosomes Cancer 2000; 28:58–65.

    Article  PubMed  CAS  Google Scholar 

  29. Oliveira AM, Tazelaar HD, Wentzlaff KA, et al. Familial pulmonary carcinoid tumors. Cancer 2001; 91:2104–9.

    Article  PubMed  CAS  Google Scholar 

  30. Cooper WA, Thourani VH, Gal AA, Lee RB, Mansour KA, Miller JI. The surgical spectrum of pulmonary neuroendocrine neoplasms. Chest 2001; 119:114–8.

    Article  Google Scholar 

  31. McCaughan BC, Martini N, Bains MS. Bronchial carcinoids. Review of 124 cases. J Thorac Cardiovasc Surg 1985; 89:8–17.

    PubMed  CAS  Google Scholar 

  32. Fink G, Krelbaum T, Yellin A, et al. Pulmonary carcinoid: presentation, diagnosis, and outcome in 142 cases in Israel and review of 640 cases from the literature. Chest 2001; 119:1647–51.

    Article  PubMed  CAS  Google Scholar 

  33. Thomas CF, Tazelaar HD, Jett JR. Typical and atypical pulmonary carcinoids. Outcome in patients presenting with regional lymph node involvement. Chest 2001; 119:1143–50.

    Article  PubMed  Google Scholar 

  34. Takada T, Takami H. Solitary splenic metastasis of a carcinoid tumor of the lung eight years postoperatively. J Surg Oncol 1998; 67:47–8.

    Article  PubMed  CAS  Google Scholar 

  35. Nakamura Y, Shimokawa S, Ishibe R, Ikee T, Taire A. Pulmonary carcinoid found in a patient who presented with initial symptoms of brain metastasis: report of a case. Surg Today 2001; 31:510–2.

    Article  PubMed  CAS  Google Scholar 

  36. Schreurs AJM, Westermann CJJ, Van den Bosch JMM, Vanderschueren RGJ, Brutel de la Rivière A, Knaepen PJ. A twenty-five year follow-up of ninety-three resected typical carcinoid tumors of the lung. J Thorac Cardiovasc Surg 1992; 104:1470–5.

    PubMed  CAS  Google Scholar 

  37. Godshall D. The carcinoid syndrome: an unusual cause of valvular heart disease. J Emerg Med 2001; 21:21–5.

    Article  PubMed  CAS  Google Scholar 

  38. Karmy-Jones R, Vallières E. Carcinoid crisis after biopsy of a bronchial carcinoid. Ann Thorac Surg 1993; 56:1403–5.

    Article  PubMed  CAS  Google Scholar 

  39. Mehta AC, Rafanan AL, Bulkley R, Walsh M, DeBoer GE. Coronary spasm and cardiac arrest from carcinoid crisis during laser bronchoscopy. Chest 1999; 115:598–600.

    Article  PubMed  CAS  Google Scholar 

  40. Thorson Å, Biörck G, Björkman G, Waldenström J. Malignant carcinoid of the small intestine with metastases to the liver, valvular disease of the right side of the heart (pulmonary stenosis and tricuspidal regurgitation without septal defects), peripheral vasomotor symptoms, bronchoconstriction, and an unusual type of cyanosis: a clinical and pathological syndrome. Am Heart J 1954; 47:795–817.

    Article  PubMed  CAS  Google Scholar 

  41. Connolly HM, Schaff HV, Mullany CJ, Rubin J, Abed MD, Pelikka PA. Surgical management of left-sided carcinoid heart disease. Circulation 2001; 104:136–40.

    Google Scholar 

  42. Aniszewski JP, Young WF Jr, Thompson GB, Grant CS, Van Heerden JA. Cushing syndrome due to ectopic adrenocorticotropic hormone secretion. World J Surg 2001; 25:934–40.

    Article  PubMed  CAS  Google Scholar 

  43. Melmed S, Ziel FH, Braunstein GD, Downs T, Frohman LA. Medical management of acromegaly due to ectopic production of growth hormone-releasing hormone by a carcinoid tumor. J Clin Endocrinol Metab 1988; 67:395–9.

    Article  PubMed  CAS  Google Scholar 

  44. Kristofferson A, Olsson T, Bjornebrink J, Hagg E. Diagnosis of ectopic ACTH production from a bronchial carcinoid by imaging with octreotide scintigraphy. Eur J Surg 1996; 162:515–8.

    Google Scholar 

  45. Kwekkeboom DJ, Krenning EP, Bakker WH, Oei HY, Kooij PPM, Lamberts SWJ. Somatostatin analogue scintigraphy in carcinoid tumors. Eur J Nucl Med 1993; 20:283–92.

    Article  PubMed  CAS  Google Scholar 

  46. Musi M, Carbone RG, Bertocchi C, et al. Bronchial carcinoid tumors: a study on clinicopathological features and role of octreotide scintigraphy. Lung Cancer 1998; 22:97–102.

    Article  PubMed  CAS  Google Scholar 

  47. Taal BG, Hoefnagel CA, Valdes Olmos RA, Boot H, Beijnen JH. Palliative effect of metaiodobenzylguanidine in metastatic carcinoid tumors. J Clin Oncol 1996; 14:1829–38.

    PubMed  CAS  Google Scholar 

  48. Marom EM, Sarvis S, Herndon JE II, Patz EF Jr. T1 lung cancers: sensitivity of diagnosis with fluorodeoxyglucose PET. Radiology 2002; 223:453–9.

    Article  PubMed  Google Scholar 

  49. Dusmet ME, McKneally MF. Pulmonary and thymic carcinoid tumors. World J Surg 1996; 20:189–95.

    Article  PubMed  CAS  Google Scholar 

  50. Carretta A, Ceresoli GL, Arrigoni G, et al. Diagnostic and therapeutic management of neuroendocrine lung tumors: a clinical study of 44 cases. Lung Cancer 2000; 29:217–25.

    Article  PubMed  CAS  Google Scholar 

  51. Marty-Ané CH, Costes V, Pujol JL, Alauzen M, Baldet P, Mary H. Carcinoid tumors of the lung: do atypical features require aggressive management? Ann Thorac Surg 1995; 59:78–83.

    Article  PubMed  Google Scholar 

  52. Sutedja G, Golding RP, Postmus PE. High resolution computed tomography in patients referred for intraluminal bronchoscopic therapy with curative intent. Eur Respir J 1996; 9:1020–3.

    Article  PubMed  CAS  Google Scholar 

  53. Codrington H, Sutedja T, Golding R, van Mourik J, Risse E, Postmus PE. Unusual pulmonary lesions: case 2. Endobronchial carcinoid of the lung. J Clin Oncol 2002; 20:2747–8.

    PubMed  Google Scholar 

  54. Kurimoto N, Murayama M, Yoshioka S, Nishisaka T, Inai K, Dohi K. Assessment of usefulness of endobronchial ultrasonography in determination of depth of tracheobronchial tumor invasion. Chest 1999; 115:1500–6.

    Article  PubMed  CAS  Google Scholar 

  55. Van Boxem TJ, Golding RP, Venmans BJ, Postmus PE, Sutedja TG. High-resolution CT in patients with intraluminal typical bronchial carcinoid tumors treated with bronchoscopic therapy. Chest 2000; 117:125–8.

    Article  PubMed  CAS  Google Scholar 

  56. Sutedja TG, Schreurs AJ, Vanderschueren RG, Kwa B, vd Werf TS, Postmus PE. Bronchoscopic therapy in patients with intraluminal typical bronchial carcinoid. Chest 1995; 107:556–8.

    Article  PubMed  CAS  Google Scholar 

  57. Mills SE, Cooper PH, Walker AN, Kron IL. Atypical carcinoid tumor of the lung. A clinicopathologic study of 17 cases. Am J Surg Pathol 1982; 6:643–54.

    Article  PubMed  CAS  Google Scholar 

  58. Grote TH, Macon WR, Davis B, Greco AF, Johnson DH. Atypical carcinoid of the lung. A distinct clinicopathologic entity. Chest 1988; 93:370–5.

    Article  PubMed  CAS  Google Scholar 

  59. Moertel CG, Kvols LK, O’Connell MJ, Rubin J. Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasms. Cancer 1991; 68:227–32.

    Article  PubMed  CAS  Google Scholar 

  60. Granberg D, Eriksson B, Wilander E, et al. Experience in treatment of metastatic pulmonary carcinoid tumors. Ann Oncol 2001; 12:1383–91.

    Article  PubMed  CAS  Google Scholar 

  61. Öberg K. Chemotherapy and biotherapy in the treatment of neuroendocrine tumours. Ann Oncol 2001; 12:S111–4.

    Article  PubMed  Google Scholar 

  62. Nobels FR, Kwekkeboom DJ, Coopmans W, et al. Chromogranin A as serum marker for neuroendocrine neoplasia: comparison with neuron-specific enolase and the alpha-subunit of glycoprotein hormones. J Clin Endocrinol Metab 1997; 82:2622–8.

    Article  PubMed  CAS  Google Scholar 

  63. Hofland LJ, Lamberts SWJ. Somatostatin receptor subtype expression in human tumors. Ann Oncol 2001; 12:S31–6.

    Article  PubMed  Google Scholar 

  64. Torre M, Barberis M, Barbieri B, Bonacina E, Belloni P. Typical and atypical bronchial carcinoids. Respir Med 1989; 83:305–8.

    Article  PubMed  CAS  Google Scholar 

  65. Rea F, Binda R, Spreafico G, et al. Bronchial carcinoids: a review of 60 patients. Ann Thorac Surg 1989; 47:412–4.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J. M. M. van den Bosch MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hage, R., de la Rivière, A.B., Seldenrijk, C.A. et al. Update in Pulmonary Carcinoid Tumors: A Review Article. Ann Surg Oncol 10, 697–704 (2003). https://doi.org/10.1245/ASO.2003.09.019

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1245/ASO.2003.09.019

Key Words

Navigation